Fusion Pharmaceuticals Inc. Long-Term Debt
Fusion Pharmaceuticals Inc. had Long-Term Debt of $49.69 million as of 2024-03-31, per its 10-Q filed 2024-05-07.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LongTermDebtNoncurrent · last filed 2024-05-07
- 2024-03-31: Long-term Debt, Excluding Current Maturities $49.69M.
- 2023-12-31: Long-term Debt, Excluding Current Maturities $34.77M.
- 2023-09-30: Long-term Debt, Excluding Current Maturities $34.63M.
- 2023-06-30: Long-term Debt, Excluding Current Maturities $34.49M.
| Period end | Long-term Debt, Excluding Current Maturities | Long-term Debt, Excluding Current Maturities as first filed |
|---|---|---|
| 2024-03-31 | $49.69M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $34.77M 10-Q · filed 2024-05-07 | |
| 2023-09-30 | $34.63M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $34.49M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $34.77M 10-Q · filed 2024-05-07 | $34.36M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $34.23M 10-K · filed 2024-03-20 | |
| 2022-09-30 | $34.11M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $9.63M 10-Q · filed 2022-08-09 |